Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-23

FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved a supplemental application for Palonosetron hydrochloride submitted by Mylan Institutional LLC. This action updates the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

SUPPL AP for PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE)